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The synaptic Ras/Rap-GTPase-activating protein (SynGAP1) plays a unique role in regulating specific downstream intracel-
lular events in response to N-methyl-D-aspartate receptor (NMDAR) activation. Constitutive heterozygous loss of SynGAP1
disrupts NMDAR-mediated physiological and behavioral processes, but the disruptions might be of developmental origin.
Therefore, the precise role of SynGAP1 in the adult brain, including its relative functional significance within specific brain
regions, remains unexplored. The present study constitutes the first attempt in achieving adult hippocampal-specific
SynGAP1 knockout using the Cre/loxP approach. Here, we report that this manipulation led to a significant numerical in-
crease in both small and large GluA1 and NR1 immunoreactive clusters, many of which were non-opposed to presynaptic
terminals. In parallel, the observed marked decline in the amplitude of spontaneous excitatory currents (sEPSCs) and inter-
event intervals supported the impression that SynGAP1 loss might facilitate the accumulation of extrasynaptic glutamatergic
receptors. In addition, SynGAP1-mediated signaling appears to be critical for the proper integration and survival of
newborn neurons. The manipulation impaired reversal learning in the probe test of the water maze and induced a
delay-dependent impairment in spatial recognition memory. It did not significantly affect anxiety or reference memory
acquisition but induced a substantial elevation in spontaneous locomotor activity in the open field test. Thus, the
present study demonstrates the functional significance of SynGAP1 signaling in the adult brain by capturing several
changes that are dependent on NMDAR and hippocampal integrity.
The brain-specific synaptic Ras/Rap GTPase-activating protein
(SynGAP1) is highly enriched at the glutamatergic postsynaptic
density (PSD) (Kennedy 1997, 2000) and is coupled to the
NMDAR complex by the scaffolding proteins PSD-95 and SAP-
102 (Chen et al. 1998; Kim et al. 1998). It is highly enriched in
the cortex andhippocampus, withweak expression in the cerebel-
lum (Kim et al. 1998). Following NMDAR activation, SynGAP1
is phosphorylated by Ca2+/calmodulin-dependent kinase II
(aCaMKII) (Krapivinsky et al. 2004; Oh et al. 2004), whereupon
it negatively regulates Ras and Rap GTPase activity and their re-
spective downstream signaling cascades (Chen et al. 1998; Kim
et al. 1998; Krapivinsky et al. 2004; Pena et al. 2008). Functionally,
SynGAP1 loss triggers extensive neuronal apoptosis (Knuesel et al.
2005) and precocious clustering of PSD-95, NMDA, and AMPA re-
ceptors at glutamatergic synapses (Kim et al. 2003; Vazquez et al.
2004; Rumbaugh et al. 2006; Carlisle et al. 2008). The loss of Syn-
GAP1 is associated with alterations in complex behavior and cog-
nitive processes including learning and memory. We and others
have recently shown that constitutive heterozygous SynGAP1
deficiency produces multiple behavioral phenotypes ranging
from hyperactivity, anxiolysis, cognitive deficits, to altered sensi-
tivity to psychomimetics (Guo et al. 2009; Muhia et al. 2009,
2010).
To date, the relevance of SynGAP1 to the genesis and main-
tenance of synapses has been demonstrated primarily in neuronal
cultures obtained from homozygous SynGAP1 knockout embry-
os. Likewise, in vivo analyses have so far been carried out in con-
stitutive heterozygous knockoutmice. Althoughmeaningful, one
cannot exclude the possible contribution by developmental
mechanisms. Hence, the precise functional significance of Syn-
GAP1 in the postnatal/adult nervous system remains ill-defined.
In line with its fundamental role during development, complete
SynGAP1 deletion is associated with premature death (Komiyama
et al. 2002; Kim et al. 2003; Vazquez et al. 2004; Knuesel et al.
2005; Barnett et al. 2006). To dissociate developmental from adult
functions, one feasible approach is to induce a region-specific
conditional knockout in adult animals. This allows us to circum-
vent the homozygous lethality and to identify the significance
of SynGAP1 in synaptic function within discrete regions of the
adult brain. The present study is the first to achieve a selective
Syngap1 gene ablation in the adult hippocampus. We used the
Cre– loxP approach by utilizing recombinant adeno-associated
virus (rAAV) vectors as a tool to deliver functional Cre (cyclization
recombination) to hippocampal cells. rAAV vectors are known
to transduce both dividing and non-dividing cells in vivo, and
the tranduced cells can be observed up to 6 mo post-injection
without indication of apoptosis or inflammatory changes (Kaspar
et al. 2002; Paterna and Bueler 2002; Di Pasquale et al. 2003; Ah-
med et al. 2004; Paterna et al. 2004). Here, adult homozygous Syn-
GAP1 floxed (SGflox/flox)mice received bilateral intra-hippocampal
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injections of either control (rAAV-EGFP) or Cre recombinase-ex-
pressing (rAAV-EGFP-Cre) viral vector constructs. The spatially re-
stricted nature of SynGAP1 knockout allowed us to examine (1) its
functional relevance to hippocampal morphology using immu-
nohistochemistry, (2) NMDAR-mediated synaptic transmission
using whole-cell recordings from transfected neurons, and (3) im-
pact on NMDAR- and hippocampal-mediated functions across
several cognitive and non-cognitive behavioral tasks.
Results
Efficient transduction of hippocampal
neurons using rAAV vectors
Four weeks following rAAV vector microinfusion, a clear and
selective transduction efficacy was evident and highly restricted
to the hippocampus (Fig. 1B,C). The EGFP expression profile was
prominent in the DG granule cell layer, hilus, CA4, and CA3 pyra-
midal cell layer subfields. CA1 pyramidal cells were sparsely la-
beled despite a strong detection of the EGFP signal in the axonal
and dendritic compartments of the stratum oriens and radiatum
(Fig. 1B). However, further verification by application of anti-
Cre antibody revealed extensive colocalization of Cre recombi-
nase and EGFP (Fig. 1D,E) and robust Cre labeling in cells from
all hippocampal subfields (Fig. 1C).There was no evidence for
anti-Cre IR in rAAV-EGFP (control) transduced cells (data
not shown), thereby confirming the specificity of the immunohis-
tochemical findings.
Moreover, dual-immunofluorescence labeling of brain sec-
tions using an antibody against the astrocytic marker, GFAP re-
vealed no immunoreactivity (IR) in EGFP-positive cells (Fig. 2A–
A′′). Thus, the rAAV vector transduction appeared neuronal-
specific.
rAAV vector expression of Cre recombinase results in
efficient deletion of the floxed SynGAP1 gene sequence
To determine the efficiency of Cre-mediated gene recombination,
we isolated EGFP-positive cells from the CA and DG hippocampal
subfields by means of laser microdissection. As depicted in Figure
2, B and C, transduced single cells expressing EGFP were outlined
and laser pressure-catapulted (LPC) into the cap of Microfuge vi-
als. Successful cell extraction and capturing were confirmed by
epifluorescence and phase-contrast microscopy of the tissue sec-
tion and caps, respectively. Subsequent nested PCR reactions of
the isolated genomic DNA from the collected cells confirmed
Cre-mediated recombination and deletion of the LoxP-flanked
SynGAP1 gene sequence (Fig. 2D).
Cre-mediated gene recombination leads to a significant
reduction of hippocampal SynGAP1 levels
To examine the impact of Cre-mediated recombination on
SynGAP1 at the protein level, we performed immunohistochemi-
cal stainings with an antibody designed against all SynGAP1 iso-
forms. Qualitative histological analysis of immunoperoxidase-
processed brain sections revealed a substantial reduction of
SynGAP1 IR in the hippocampi of rAAV-EGFP-Cremice compared
with controls (Fig. 3A–D). This was particularly prominent in
the DG dendritic and the CA1–CA4 subfields. Densitometrical
analysis of the DAB reaction product yielded significant reduc-
tions of SynGAP1 1R in rAAV-EGFP-Cre mice in CA1 stratum
radiatum (223.8%, P, 0.001), CA3 stratum radiatum (242.1%,
P, 0.05), and CA4 stratum radiatum (235%, P, 0.01) compared
with control mice. Notably, GABAergic interneurons in rAAV-
EGFP-Cre injected mice were still positive for SynGAP1 staining
(Fig. 3C,D′′).
Absence of toxic effects from rAAV vector delivery
Transgene expression did not appear to exert any toxicity to the
transduced cells as evidenced by a clearly intact neuronal mor-
phology and the presence of numerous dendritic spines (Fig.
2A). In addition, anti-Iba-1 IR, a marker for activated microglia,
was indistinguishable between that of rAAV-EGFP-Cre and
rAAV-EGFP controls (Fig. 3E,F). We did not observe any changes
in the ramifications nor in the cell bodies of microglia in
rAAV-EGFP-Cre tissue, suggesting the absence of rAAV-induced in-
flammationor degeneration. Further confirmation byoptical den-
sitometrical analysis of the Iba-1 IR did not yield any statistically
significant difference between rAAV-EGFP (rel. ODHip ¼ 33.31+
2.94) and rAAV-EGFP-Cre (rel. ODHip ¼ 33.76+4.47; P ¼ 0.93)
brain sections.
Figure 1. Efficient and localized transduction of rAAV vectors. (A)
Schematic representation of the SynGAP1 floxed (SGflox) allele. The
SGflox/flox mutant line harbors two LoxP sites flanking exons 4–9 of the
SynGAP1 gene coding sequence. Cre-mediated knockout of LoxP-flanked
SynGAP1 gene sequence occludes the transcription of all four SynGAP1
isoforms (Vazquez et al. 2004; Knuesel et al. 2005). (Red) Primers used
for nested PCR to confirm Cre recombinase-mediated gene deletion. (B)
Low-magnification mosaic fluorescence image depicting a strong and
hippocampus-specific expression profile of EGFP in rAAV-EGFP mice 4
wk post-intrahippocampal viral vector delivery. (C) Coimmunofluores-
cence staining showing the prominent dendritic EGFP signal (green,
left) and somatic anti-Cre (red, right) immunoreactivity in both dentate
gyrus (DG) granule cells and pyramidal neurons in the hippocampus
after rAAV-EGFP-Cre injection. (D) Higher magnification of granule cells
in the DG showed prominent EGFP labeling and anti-Cre immunoreactiv-
ity. (E) Antigen retrieval using pepsin pre-treatment allowed optimal visu-
alization of Cre-positive cells yet reduced surface EGFP signals, leading to
partial colocalization of the two proteins. Scale bars, (B) 500 mm; (C)
300 mm; (D) 30 mm; (E) 8 mm.
Hippocampal deletion of SynGAP1
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Cre recombination of the floxed SynGAP1 gene
sequence is associated with alterations
in glutamatergic receptor expression
SynGAP1 plays a critical role in synaptogenesis and spine mor-
phology during development and adulthood as shown by in vitro
and in situ experiments involving either cultured neurons
obtained from SG2/2 embryos (Kim et al. 2003; Vazquez et al.
2004; Rumbaugh et al. 2006) or brain slices from adult heterozy-
gous SG+/2 mice (Carlisle et al. 2008). Here, brain sections ob-
tained from experimentally naive rAAV-EGFP-Cre- and rAAV-
EGFP-injected mice were processed for anti-NR1 and anti-GluA1
immunohistochemistry to examine the impact of conditional
adult hippocampus SynGAP1 knockout on NMDA and AMPA
receptor clustering and distribution. Brief pepsin pre-treatment
allowed optimal visualization of both glutamate receptor sub-
types in DG and CA dendritic subfields as shown by the represen-
tative image of the DG molecular layer in rAAV-EGFP-injected
mice (Fig. 4A).
GluA1-immunoreactive puncta were closely associated with
EGFP-filled neurites, likely representing glutamatergic synapses
on dendritic spines (Fig. 4A′′). An increase in GluA1-positive
cluster size was observed in rAAV-EGFP-Cre injected tissue
compared with the control mice. Statistical analyses of the densi-
tometrical evaluations of the size and the brightness (expressed
as integrated pixel density) of GluA1-immunoreactive clusters
in the hippocampus confirmed these observations and revealed
a significant increase following SynGAP1 deletion in the DG
molecular layer (ml) (Student’s t-test, t ¼ 26.3, P, 0.001), CA1
stratum radiatum (sr) (t ¼ 22.2, P ¼ 0.025), CA3 sr (t ¼ 24.6,
P, 0.001), and lucidum (sl) (t ¼ 26.3, P, 0.001) (Fig. 4C).
Similarly, statistical comparison of the cluster size distribution
yielded a significant treatment effect for the DG ml (KS-test,
df ¼ 2, Dmax ¼ 0.05, x2 ¼ 107.31, P, 0.0001), CA3 sr (df ¼ 2,
Dmax ¼ 0.02, x2 ¼ 16.4, P, 0.001), and sl (df ¼ 2, Dmax ¼ 0.04,
x2 ¼ 29.8, P, 0.0001), indicating an overall shift toward larger
clusters in rAAV-EGFP-Cre mice compared with controls. In CA1
sr, differences in cluster size distribution between treatment
groups only approached significance (KS-test, df ¼ 2, Dmax ¼
0.02, x2 ¼ 6.1, P ¼ 0.09). The analysis also revealed a prominent
increase in the number of small GluA1-positive clusters (size
range from 0.02 to 0.1 mm2) in hippocampal brain sections
of rAAV-EGFP-Cre compared with control mice (DGml, KS-test,
df ¼ 2, Dmax ¼ 0.02, x2 ¼ 6.1, P ¼ 0.006) (Fig. 4C), suggesting
an increase in the number of newly formed glutamatergic
synapses.
Highly similar results were obtained using anti-NR1 immu-
nohistochemistry. Double-fluorescence microscopy revealed a
positive association of NR1-immunoreactivity with EGFP-posi-
tive dendrites in both DG and CA subfields (data not shown).
The NR1-postive clusters were significantly enlarged in rAAV-
EGFP-Cre mice compared with rAAV-EGFP controls, resulting
in a significant increase in the area and size of NR1-immuno-
reactive signals (integrated pixel brightness) in the DG ml
(t ¼ 23.1, P ¼ 0.002), CA1 sr (t ¼ 24.6, P, 0.001), and CA3 sr
(t ¼ 3.2, P ¼ 0.002). Statistical comparison between the two treat-
ment groups yielded a significant shift of the cumulative size
distribution curve toward larger values in rAAV-EGFP-Cre versus
control subjects (KS-test, DG ml, df ¼ 2, Dmax ¼ 0.02, x2 ¼ 9.06,
P ¼ 0.02; CA3 sr, df ¼ 2, Dmax ¼ 0.02, x2 ¼ 10.4, P ¼ 0.01; CA1
sr, df ¼ 2,Dmax ¼ 0.04, x2 ¼ 50.0, P, 0.001) (Fig. 4C). These find-
ings suggest that conditional hippocampus-specific SynGAP1
knockout might lead to elevated glutamatergic synapse for-
mation, including abnormal insertion of NMDA and AMPA
receptors.
Figure 2. Efficient Cre-mediated SynGAP1 gene recombination. (A)
Neuronal-specific rAAV vector-mediated transduction. Representative
high-magnification images of rAAV-EGFP expressing neuronal dendrites
in the DG molecular layer. Anti-GFAP immunostaining (A′, red) and
merged image (A′′) shows the tight neuron-astrocyte association but no
colocalization of the two cell types. (B) Epifluorescence images depicting
EGFP-positive neurons before and after successful LPC removal. (C)
Phase-contrast images show the typical trace of the nitrogen laser
(337 nm) following microdissection (arrows) and the empty space there-
after. (D) Following rAAV vector delivery, efficient Cre-mediated recombi-
nation leads to complete deletion of the LoxP-flanked SynGAP1 gene
sequence. (Left) First-stage PCR of genomic DNA from Cre recombinase-
negative (and EGFP-negative) (lane 1) and -positive (lanes 2, 3) hippo-
campal neurons using the MGEX9-I/MGIN11 primer pair. Lane 1 (no re-
combination) renders a 1800-bp PCR band, which is not detectable in
Cre-expressing EGFP-positive cells, where the binding sequence of
MGEX9-1 is absent following Cre-mediated recombination. (Middle,
second-stage PCR) PCR products from first-stage PCR were combined
with the 5SG-1/3SGn primer pair. A 400-bp PCR product was detected
from genomic DNA of Cre recombinase-negative neurons (lane 1, no re-
combination), but was either undetectable (lane 3) or weakly present
(lane 2), indicating efficient in vivo SynGAP1 gene recombination.
(Right) Confirmation of the presence of the LPC-isolated and extracted
genomic DNA in all samples; first-stage PCR was performed using the
LoxDS/MGINII primer pair, which binds with the SynGAP1 gene irrespec-
tive of the recombination status. A strong diagnostic 400-bp PCR product
was detected in all lanes, indicating the presence of genomic DNA in all
samples. Scale bars, 10 mm.
Hippocampal deletion of SynGAP1
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Functional alterations in glutamatergic neurotransmission
associated with SynGAP1 knockout
The abnormal increase in size and number of GluA1- and
NR1-positive synaptic clusters suggested that the absence of
SynGAP1might have an impact on glutamatergic neurotransmis-
sion. We investigated this by performing whole-cell patch-clamp
recordings of CA1 neurons of hippocampal slices obtained from
SGflox/flox mice 4 wk after unilateral delivery of rAAV-EGFP-Cre-
(n ¼ 4) or rAAV-EGFP-injected mice (n ¼ 3). Both the frequency
and amplitude of spontaneous excitatory post-synaptic currents
(sEPSCs) were analyzed using three to six slices per animal. The
non-injected hippocampus served as internal control. Statistical
comparisons between control and injected hemispheres revealed
a significant reduction in the sEPSC amplitude (KS-test: Dmax ¼
0.2, P, 0.001) (Fig. 5A). This was accompanied by an increase
in sEPSC frequency as shown by the significant decrease in inter-
event intervals (KS-test: Dmax ¼ 0.3, P, 0.001) (Fig. 5B), likely re-
lated to the observed increase in numerical density of small NR1/
GluA1-immunoreactive clusters. Recordings using control viral
vectors did not reveal significant differences between the two
hemispheres (data not shown).
Post hoc immunohistochemical analyses were performed to
verify ipsilateral and contralateral hemispheres and to confirm
the impact of SynGAP1 deletion on glutamatergic receptor local-
ization and density. In line with our semi-quantitative evaluation
of the NR1/GluA1 immunoreactivity between treatment groups,
the qualitative immunohistochemical analysis following the elec-
trophysiological recordings confirmed a substantial enlargement
of NR1- and GluA1-positive clusters following SynGAP1 deletion.
Coimmunofluorescence staining using anti-NR1 or GluA1 in
combination with anti-VGlut1 (vesicular glutamate transporter
1) revealed that the abnormally large glutamate receptor clusters
were not opposed to VGlut1 terminals (Fig. 5C,D). This observa-
tion suggested that the enlargement of NR1- andGluA1-immuno-
reactive clusters may stem from extrasynaptic accumulation of
glutamate receptors, which might underlie the reduced sEPSC
amplitude.
Reduction in DCX-positive neurons following
conditional SynGAP1 deletion
Based on our previous observation of a significant reduction in the
number of newborn neurons in the DG subgranular zone of het-
erozygous SynGAP1 knockout (SG+/2) mice (Muhia et al. 2010),
we investigated whether the absence of SynGAP1 in our condi-
tional knockout model might lead to abnormal survival and inte-
gration of adult newborn neurons in the hippocampal circuitry.
Immunohistochemical staining using an antibody against dou-
blecortin (DCX), an endogenous marker for newborn neurons
(Couillard-Despres et al. 2005), revealed a very lownumerical den-
sity of DCX-positive neurons in rAAV-EGFP-Cre- compared with
rAAV-EGFP-injected mice (Fig. 6C–E). Statistical analysis revealed
a significant reduction of DCX-positive neurons in rAAV-EGFP-
Cre mice compared with controls (ANOVA, F(1,14) ¼ 42.87, P,
0.0001). There was an overall increase in the number of DCX-pos-
itive newborn cells coexpressing activated caspase-3 (Fig. 6B), in-
dicating elevated apoptotic loss of newly formedneurons in rAAV-
EGFP-Cre-injected versus control mice. Interestingly, DCX-posi-
tiveneuronswere also found in thehilar region following deletion
of the floxed Syngap1 gene (Fig. 6D), a phenomenon not observed
in rAAV-EGFP controls, suggesting that reduced SynGAP1 expres-
sion and accompanying reduction in glutamatergic neurotrans-
mission result in abnormal migration and reduced survival of
newborn neurons.
Behavioral characteristics of hippocampal-specific
SynGAP1 knockout
The morphological and electrophysiological findings prompted
us to examine the behavioral impact of this manipulation on hip-
pocampal and NMDAR-dependent tests, which had revealed
marked learning deficits in constitutive heterozygous SynGAP1
knockout mice (Muhia et al. 2010). The results are presented ac-
cording to the outcome of the cognitive tests due to their signifi-
cance and relevance to the nature of themanipulation rather than
in chronological order.
Figure 3. Conditional deletion of the SGflox allele results in a significant
loss of SynGAP1 immunoreactivity in the hippocampus. (A,B) Representa-
tive images of coronal brain sections processed for anti-SynGAP1 immu-
nohistochemistry. The images have been color-coded for visual display;
(yellow-white) the strongest immunoreactivity; (dark purple/black)
background levels. Note the selective reduction in SynGAP1 following
intrahippocampal delivery of the rAAV-EGFP-Cre virus. (C,D) Higher-mag-
nification images of the immunoperoxidase staining of SynGAP1 in the
dorsal hippocampus of rAAV-EGFP (C) and rAAV-EGFP-Cre (D) injected
mice 4 wk post-intrahippocampal viral vector delivery. A significant
reduction in SynGAP1 immunoreactive signal was evident throughout
the hippocampus, particularly prominent in the DG and CA dendritic
fields. Residual SynGAP1 immunoreactivity was detected in GABAergic
neurons expressing the GABAA receptor a1 subunit in the CA1 stratum
pyramidale (stp, arrows), representing non-transduced interneurons in
rAAV-EGFP-Cre (D′,D′′) compared with control mouse brain sections
(C′,C′′). (E,F) Immunoperoxidase staining using the microglial marker
Iba1 on hippocampal brain sections of rAAV-EGFP (E) and rAAV-EGFP-Cre
(F) injected mice. Note the absence of microglial activation following
intrahippocampal viral vector delivery. (ml) Molecular layer; (str)
stratum radiatum. Scale bars, (A) 1 mm; (C,E) 200 mm; (C′,D′) 20 mm;
(C′′,D′′) 10 mm.
Hippocampal deletion of SynGAP1
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Morris water maze task
Visible cued test performance
Mice were first familiarized to the basic water maze escape proce-
dure in order to examine for changes in motivation as well as
sensory and motor (visual and swimming) function. Both treat-
ment groups readily learned the escape response (Fig. 7A,B),
with performance improving across the four trials (latency:
F(3,90) ¼ 5.78, P, 0.001; path length: F(3,90) ¼ 10.12, P, 0.001).
Although amain effect of Treatment did not achieve statistical sig-
nificance in the analysis of average swim speed, a significant
Treatment-by-Sex interaction (F(1,30) ¼ 6.13, P, 0.05) emerged,
as a consequence of a sex-dependent effect on swim speed:
SynGAP1 deletion in the hippocampus reduced swim speed in
the male mice (rAAV-EGFP ¼ 16.3+1.2 vs. rAAV-EGFP-Cre ¼
13.3+1.1 cm/sec) but enhanced it in the female (rAAV-EGFP ¼
14.2+1.2 vs. rAAV-EGFP-Cre ¼ 16.7+1.1 cm/sec). This suggest-
ed to us that the escape latencymeasure might not be an effective
unbiased index of performance, and therefore the path length
measure (being independent of speed) is chosen here as the per-
formance measure.
Reference memory: acquisition
Here, the fixed escape platform location
allowed for gradual improvement in
performance, which was accompanied
by subsequent development of spatial
bias for the target location. Across the
8 d of training, both treatment groups
improved in acquisition and showed a
progressive decline in path length (Fig.
7C, Acquisition). Consistent with this
impression, a 2 × 2 × 8 (Treatment ×
Sex × Days) split-plot ANOVA of path
length yielded a highly significant
main effect of Days (F(7,210) ¼ 5.48, P,
0.001). The analysis also yielded a trend
toward increased path length in the
rAAV-EGFP-Cre mice (F(1,30) ¼ 3.10, P ¼
0.089), although the critical Treatment-
by-Days interaction term did not ap-
proach significance (F, 1). Additional
analyses restricted to the first trial of
each day yielded only a significant effect
of Day (F(7,210) ¼ 6.46, P, 0.001), sug-
gesting successful retention abilities
for the platform’s spatial location during
acquisition.
Probe test 1
A probe test was performed 24 h after the
last acquisition trial, in which the plat-
form was removed from the pool and
the mice were allowed to swim for 60
sec. To gauge the spatial search strategy,
we examined the proportion of percent-
age path length in the target quadrant
relative to the other quadrants (Fig. 7D).
A 2 × 2 × 4 (Treatment × Sex × Quad-
rants) ANOVA of percentage path length
yielded a main effect of Quadrants
(F(3,90) ¼ 6.38, P, 0.01), which suggest-
ed efficient retention of the platform’s
spatial location. Although both treat-
ment groups showed a preference for
the target quadrant, this bias appeared
weaker in the rAAV-EGFP-Cre mice com-
pared with controls (Fig. 7D). We therefore performed a one-
sample t-test for the target quadrant against chance level perfor-
mance (25%). It revealed that whereas the rAAV-EGFP control
mice exceeded chance level preference for the target quadrant
(P, 0.05), the rAAV-EGFP-Cre mice failed to do so (P ¼ 0.09).
Reversal learning
Next, the hidden platform was switched to the opposite quadrant
to assess the animal’s ability to learn a novel platform location
against interference from the previously acquired memory trace
of the former platform location. The initial impact of reversal
was apparent in both treatment groups (Fig. 7C, Reversal). This
impressionwas examined by comparing the last day of acquisition
training (day 8) against the first day of reversal (day 10), which re-
vealed a near-significant effect of Days (F(1,30) ¼ 4.04, P ¼ 0.05).
However, there was little improvement in escape performance
over the 6 d of reversal training (Fig. 7C). A 2 × 2 × 6
(Treatment × Sex × Days) split-plot ANOVA of path length failed
to yield any indication of inter-day improvement. No other signif-
icant main effects or interactions emerged.
Figure 4. Ablation of the SGflox allele leads to an increase in number and size of GluR1- and
NR1-positive clusters. (A) Double-fluorescence images acquired in the DG molecular layer of brain sec-
tions from rAAV-EGFP (A–A′′) and rAAV-EGFP-Cre injected mice (B–B′′). (Green staining) EGFP-filled
dendrites of viral-transduced granule cells; (red staining) anti-GluR1 staining in the same field of
view. The boxes in A′ and B′ show an enlarged view of the molecular layer with distinct immunoreactive
signals, which likely represent glutamatergic synapses on dendritic spines. (C) Quantitative analysis of
the cluster size distribution revealed significant differences between the two treatment groups, both
with respect to the frequency of small clusters (,0.05 mm2) as well as the integrated pixel brightness
of individual immunoreactive puncta, pointing to the elevation of newly formed and at the same
time enlargement of existing glutamatergic synapses/spines in rAAV-EGFP-Cre mice compared with
the control group. Statistics based on two-sample Kolmogorov-Smirnov and Mann–Whitney U-test.
Scale bar, 10 mm.
Hippocampal deletion of SynGAP1
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Probe test 2
Nevertheless, when the probe test was introduced 24 h after the
last reversal trial, rAAV-EGFP control mice showed a distinct
spatial preference for the novel target quadrant, indicating reten-
tion of the novel platform location. However, rAAV-EGFP-Cre
mice failed to show an equivalent preference and appeared to
search more in the former target location (Fig. 7E). A 2 × 2 × 4
(Treatment× Sex× Quadrants) ANOVA of percentage path length
yielded a main effect of Quadrants (F(3,90) ¼ 3.93, P, 0.05) and a
marginally significant Treatment-by-Quadrant interaction
(F(3,90) ¼ 2.44, P ¼ 0.07). The latter was examined further by
ANOVA restricted to each treatment group followed by pairwise
comparisons. In the control group, the analysis revealed a signifi-
cant main effect of Quadrant (F(3,42) ¼ 5.65, P, 0.01) and signifi-
cant difference between the target and opposite previously
reinforced quadrant (P, 0.05). Preference for the target quadrant
exceeded chance level (25%) performance following an additional
one-sample t-test (P, 0.05). None of these measures attained sig-
nificance in the analysis for rAAV-EGFP-Cre mice.
Delay-dependent deficit in spatial recognition memory
in the Y-maze
We also examined the short-termmemory of recent exposure to a
spatial location by assessing spatial novelty preference in the
Y-maze task (Sanderson et al. 2007; Bannerman et al. 2008). In
the sample phase, both treatment groups performed similarly in
terms of the time spent exploring the start and fa-
miliar arms. There were no statistically significant
main effects or interactions. However, across all de-
lay intervals, rAAV-EGFP-Cre mice showed in-
creased locomotor activity compared with rAAV-
EGFP controls (F(1,30) ¼ 6.77, P, 0.05). In the test
phase conducted subsequently, both treatment
groups demonstrated a preference to explore the
previously not-visited (i.e., novel) arm (F(1,60) ¼
4.97, P, 0.05) in a 2 × 2 × 2 × 3 (Treatment ×
Sex × Arms × Delays) ANOVA of time spent in
each arm. The analysis also yielded a significant
two-way interaction between Treatment and
Delay (F(2,60) ¼ 4.45, P, 0.05), which was exam-
ined further by performing ANOVAs restricted
to each delay interval. A significant Treatment-
by-Arms interaction emerged at the 1-h delay
condition (F(1,30) ¼ 6.07, P, 0.05). Subsequent
post hoc comparisons indicated that this effect
stemmed froma significant decrease in the explora-
tion of the novel arm by rAAV-EGFP-Cremice com-
pared with controls (F(1,30) ¼ 6.05, P, 0.05).
Consistent with previous observations in the
sample phase, rAAV-EGFP-Cre mice showed sig-
nificantly enhanced locomotor activity compared
with the rAAV-EGFP control mice (F(1,30) ¼ 13.15,
P, 0.01). Similarly, a 2 × 2 × 3 (Treatment ×
Sex × Delay) ANOVA of percent time spent in the
novel arm yielded a significant Treatment × Delay
interaction (F(2,60) ¼ 3.53, P, 0.05). Subsequent
post hoc analysis revealed that this interaction
stemmed from significantly less exploration of
the novel arm by the rAAV-EGFP-Cre mice in the
1-hdelay interval (Fig. 8B) (F(1,30) ¼ 6.72, P, 0.05).
Anxiety-related behavior and
locomotor activity
To examine the impact of hippocampus-specific
SynGAP1 knockout in the non-cognitive domain,
we assessed the performance of rAAV-EGFP-Cremice in the elevat-
ed plus maze test of anxiety. As indicated above, this test was per-
formedwhen animals were behaviorally naive. A tendency toward
increased anxiety was seen in rAAV-EGFP-Cre mice compared with
controls. Themean percentage time spent in the open arms for the
rAAV-EGFP-Cre and rAAV-EGFPcontrolmicewas 26.1+7.1 sec and
41.6+7.5 sec, respectively. Likewise, the mean percentage of en-
tries into the open arms was as follows: rAAV-EGFP-Cre (33.6+
6.1) and rAAV-EGFP controls (47.1+6.4). Statistical analysis, how-
ever, failed to yield a significant group effect in terms of either per-
centageopenarmentries orpercentage time spent in theopenarms
(% Frequency: F(1,30)¼ 2.31, P ¼ 0.14; % Time: F(1,30)¼ 2.25, P ¼
0.15).
In the open field, the rAAV-EGFP-Cre mice showed a sub-
stantial and consistent elevation in locomotor activity compared
with control subjects (Fig. 8A), as evidenced by a split-plot
(Treatment × Sex × Bins) ANOVA, which yielded a significant ef-
fect of Treatment (F(1,30) ¼ 4.77, P, 0.05). A gradual reduction
in activity as a function of time was evident from the main effect
of Bins (F(5,150) ¼ 40.68, P, 0.01).
Discussion
The present study investigated for the first time the functional im-
pact of adult hippocampus-specific SynGAP1 gene deletion and
provides evidence for SynGAP1 function in adult synaptic
Figure 5. Hippocampus-specific loss of SynGAP1 alters excitatory neurotransmission.
Whole-cell voltage-clamp recordings of spontaneous excitatory events were performed in
acute brain slices at 4 wk post-virus injection. (A,B) Cumulative probability distribution of
the amplitudes (A) and inter-event intervals (B) measured in the ipsilateral and contralateral
(control) hemisphere of rAAV-EGFP-Cre-injected mice. (C,D) Post hoc immunohistochemical
analyses revealed a marked increase in extrasynaptic glutamate receptors on the ipsilateral
versus contralateral hippocampus as shown by the increase in anti-GluR1 immunoreactive
clusters that were not opposed to presynaptic glutamatergic (positive for vesicular glutamate
transporter, VGlut1) terminals (enlarged view in D′). Scale bars, 5 mm.
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function. The restricted nature of themanipulation was sufficient
to induce significant modifications in hippocampal morphology
and its mediated neurophysiological and behavioral functions.
These changes comprised a significant increase in the numerical
density of synaptic glutamate receptors, their enlargement at
extrasynaptic sites, and corresponding changes in excitatory neu-
rotransmission. Furthermore, we showed a reduction in the num-
ber of DG newborn neurons and demonstrated several changes in
cognitive and non-cognitive behavioral functions following this
manipulation.
Here, rAAV vector expression was restricted to the dorsal and
ventral hippocampus. The serotypes used (5/2 and 8/2) preferen-
tially targeted neurons with no indication of astroglial transduc-
tion, reactive gliosis, or evidence of toxicity. This observation
complements multiple studies that have used comparable titers
of rAAV-Cre vectors (Kaspar et al. 2002; Scammell et al. 2003;
Ahmed et al. 2004; Paterna et al. 2007).We demonstrated efficient
and focal deletion of the floxed coding sequence by PCR of isolat-
ed genomic DNA from transduced cells. Despite a concomitant
significant decrease in SynGAP1 protein levels, we did not observe
a complete loss in the hippocampus. This may stem from low
SynGAP1 protein turnover levels, which have yet to be estab-
lished. Transduction of GABAergic interneurons also appeared
limited as evidenced by few remaining SynGAP1-positive cells.
This phenomenon is not surprising given that prior studies using
viral Cre recombinase delivery showed pronounced but not com-
plete deletion of the floxed alleles (Scammell et al. 2003; Inturrisi
2005; Glass et al. 2008; Lee et al. 2008). Nonetheless, the viral
vector-mediated Cre recombinase delivery applied here yielded a
highly efficient and consistent genetic deletion across subjects
compared with the more variable gene deletion efficiency using
other, conditional breeding strategies (Knuesel et al. 2005).
Neuroanatomical and neurophysiological phenotypes
The observed significant increase in the number and size of
GluA1- and NR1-immunoreactive clusters parallels prior in vitro
studies demonstrating that SynGAP1 loss induces precocious glu-
tamatergic synapse formation, presumably due to aberrant re-
cruitment of synaptic AMPA and NMDA receptors (Krapivinsky
et al. 2004; Vazquez et al. 2004; Rama et al. 2008). Vazquez et al.
(2004) reported that SynGAP1 knockout triggers earlier synapse
and spine formation, which ultimately become larger compared
with controls. Hence, it is plausible that the increase of smaller
GluA1- and NR1-positive clusters seen here might be indicative
of elevated synapse formation, while the larger clusters could rep-
resent abnormalities in synapse maturation and accumulation of
extrasynaptic receptors. In line with this view, our electrophysio-
logical data revealed a significant increase in inter-event intervals
of excitatory postsynaptic currents, further confirming the eleva-
tion of synaptic glutamate receptors. On the other hand, the am-
plitudes of the postsynaptic currents were significantly decreased
in SynGAP1 knockout slices compared with controls and were in-
deed accompanied by a pronounced increase in extrasynaptic glu-
tamate receptors. These findings partially complement a recent
study showing a substantial increase in number and head volume
of largemushroom spines in hippocampal pyramidal cells of adult
SynGAP+/2 mice (Carlisle et al. 2008). However, the same study
did not report a genotypic effect with respect to numerical density
andmorphology of stubby and thin protrusions, which likely rep-
resent less-mature spines. One interpretation is that while the loss
of a single SynGAP1 allele may be sufficient to perturb spine mor-
phology, a complete or near complete loss of both copies is re-
quired to induce/accelerate synapse formation.
It has been shown that changes in AMPA receptor surface ex-
pression stem from disturbances of the SynGAP1–ERK signaling
cascade (Rumbaugh et al. 2006). This biochemical event is shown
to critically determine glutamate receptor surface expression and
regulate spine dynamics (Gao et al. 2011). Collectively, it is con-
ceivable that the SynGAP1-mediated signaling pathway essential
for glutamatergic synapse formation during development may
play a similar role in adulthood by controlling synapse number
and morphology, as well as adaptive synaptic changes involving
synaptic glutamate receptor insertion.
Finally, in linewith previous findings (Muhia et al. 2010), de-
creased hippocampal neurogenesis suggested a role for SynGAP1
in neuronal survival and integration of newborn neurons. This
might be expected given that SynGAP1 mediates the Ras-ERK sig-
naling cascade; a key modulator of multiple effects of neurotro-
phic factors, including neuronal differentiation, proliferation,
and survival (Kaplan and Miller 2000; Huang and Reichardt
2003). Additionally, our observed colocalization of activated cas-
pase-3 with some of the DCX cells concurs with previous observa-
tions of increased apoptotic cell death following conditional
SynGAP1 knockout in the developing brain and adult DG
(Knuesel et al. 2005). One possible explanation for this might be
linked to SynGAP1′s regulation of n-cofilin activity and its
Figure 6. Cre recombinase-mediated ablation of the SGflox allele pre-
vents the formation of new born neurons. (A,B) Triple-fluorescence
images taken from the dentate gyrus subgranular layer of rAAV-EGFP- (A)
and rAAV-EGFP-Cre-injected (B) mice. (Green staining) Transduced
dentate gyrus granule cells; (red staining) the same field of view with
anti-DCX staining, characteristically localized to the DG subgranular
zone. The presence of apoptotic neurons was examined using an antibody
against activated caspase-3 (blue), a key player in executing apoptotic
signals. (C–D) Anti-DCX immunohistochemical staining to visualize
newly generated neurons in the adult dentate gyrus (DG). rAAV-EGFP-
Cre-injected mice (D) show a significantly lower number of DCX-positive
cells in the subgranular zone of theDG comparedwith rAAV-EGFP-injected
mice (C). (C′,D′) Enlarged view of the granule cell layer of the correspond-
ing treatment groups. (D′′)Note the presence of ectopicDCX-positive cells
in the hilus of rAAV-EGFP-Cre subjects. (E) Quantification of the total
number of DCX-positive cells. (∗∗∗) P, 0.0001. Scale bars, 10 mm.
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modulation of F-actin depolymerization in mature spines. Loss of
SynGAP1 leads to prolonged n-cofilin phosphorylation, which in-
terferes with F-actin assembly, subsequently leading to actin cyto-
skeleton stabilization (Carlisle et al. 2008). Interestingly, recent
findings confirm that forebrain-specific deletion of n-cofilin and
its associated loss in synaptic actin dynamics leads to associative
learning impairments (Rust et al. 2010). Hence, it is plausible
that SynGAP1 deficiency significantly impairs spine morphology
and motility, thereby disrupting excitatory synapse function that
is fundamental for proper migration and integration of newborn
neurons into neuronal circuits (Aimone et al. 2010). The observa-
tionof severalDCX-positiveneurons in thehilus andexpressionof
activated caspase-3 by some of these cells indeed suggests abnor-
mal migration and integration of newborn neurons following
loss of SynGAP1 signaling.
Mnemonic phenotype
Although a direct causal link cannot be confirmed here, we can
speculate that the ensuing behavioral phenotype might be linked
to the significant reductions in hippocampal SynGAP1 protein
content and the distinct morphological and electrophysiological
changes associated with SynGAP1 disruption.
In the water maze, rAAV-EGFP-Cre mice successfully ac-
quired the reference memory (RM) task and showed preference
for the training quadrant. Yet, there was some indication of in-
creased path length, and their preference for the target quadrant
was less pronounced than controls. This seems to reflect a less ef-
ficient strategy in finding the platform
rather than a gross impairment in acqui-
sition/retention as such. In contrast,
profound reference memory deficits are
seen following NMDAR pharmacologi-
cal blockade (Morris et al. 1986) or hip-
pocampectomy (Morris et al. 1982;
Bannerman et al. 2004; Pothuizen et al.
2004). Hence, it appears that the tempo-
ral and spatial restricted nature of the
current manipulation is insufficient to
induce clear deficits in RM acquisition
and retention. Nonetheless, it has been
shown thathippocampal-subfield-specif-
ic manipulations of the NMDA NR1 re-
ceptor subunit lead to spatial working
memory deficits with little impact on
reference memory function (Nakazawa
et al. 2002,2003;Niewoehneret al. 2007).
In the same task, a deficit emerged
when the platform was re-located to the
opposite quadrant—rAAV-EGFP-Cre mice
failed to show spatial bias toward the
novel target quadrant, in sharp contrast
to the dominant preference seen in
rAAV-EGFP controls. The deficit was
tentative during training (Fig. 7C) but
emerged most clearly in the subsequent
probe test (Fig. 7E). It is unlikely that
this deficit stemmed from inadequate ac-
quisition/retention abilities, given that
they acquired the RM procedure. Hence,
the lack of spatial bias toward the new
platform location suggested an underly-
ing anomaly in cognitive flexibility. It is
worth noting that a similar pattern of
performance in water maze learning has
been demonstrated in mice deficient in
aCaMKII function, namely, normal RM acquisition but impaired
reversal (Elgersma et al. 2002). Additionally, decreased adult
dentate gyrus (DG) neurogenesis leads to deficits inwatermaze re-
versal (Garthe et al. 2009). Given that SynGAP1 is highly phos-
phorylated by aCaMKII (Krapivinsky et al. 2004; Oh et al. 2004),
it is plausible that disruption of the SynGAP1–aCaMKII biochem-
ical event, including decreased neurogenesis (Fig. 6) contributes
Figure 7. Spatial reference memory and reversal learning in the Morris water maze task. Both treat-
ment groups acquired the visible platform task across trials based on escape latency (A) and path length
(B). (C) Acquisition: Both treatment groups showed progressive decline in path length across training.
Reversal: Performance when the platform was shifted to the opposite target quadrant. (D) In probe test
1, both treatment groups showed preference for the target quadrant, although this appeared less pro-
nounced in the rAAV-EGFP-Cre mice compared with controls. (E) In probe test 2 after reversal,
rAAV-EGFP-Cre mice failed to show preference for the new target quadrant. Dotted line depicts
chance Chance level performance (at 25%). Values are expressed as mean+SEM; (∗) P, 0.05.
Figure 8. (A) Spontaneous locomotor activity in the open field test ex-
pressed as total distance traveled over the 60-min session. (B)
Spontaneous spatial alternation in the Y-maze. Preference for the novel
arm, as indexed as percent time spent in the novel arm was attenuated
in the 1-h retention interval in rAAV-EGFP-Cre mice; (∗) P, 0.05. All
values are expressed as mean+SEM.
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to the reversal deficit seen here. In line with this speculation, Syn-
GAP1heterozygous knockoutmice show decreasedDGneurogen-
esis and gross impairments in the rapid and flexible switching
required for working memory function (Muhia et al. 2010).
Deficits in the spontaneous spatial novelty taskmight be tak-
en as impaired familiarity judgment, which translates to an inabil-
ity to discriminate familiar over novel arms (Sanderson et al. 2007;
Engelhardt et al. 2008). Here, the deficit in rAAV-EGFP-Cre mice
emerged only in the longer delay interval, which suggested that
hippocampus-specific SynGAP1 knockout is unlikely to interfere
with general novelty preference. Yet, it appears from the delay-
dependent nature of the impairment that SynGAP1 deficiency
compromises working memory function when an increase in
memory load, in terms of retention interval, is imposed.
Nonmnemonic phenotypes
A phenotype beyondmnemonic function emerged in the form of
enhanced spontaneous locomotor activity in rAAV-EGFP-Cre
mice. This is compatible with previous studies in SynGAP1+/2
mice (Guo et al. 2009; Muhia et al. 2010), further substantiating
the robustness of this phenotype, and identifies it as stemming
primarily from a loss of hippocampal SynGAP1. Additionally,
the hyperactivity phenotype observed here is compatible with
known effects of hippocampal damage on locomotor activity
(Gray and McNaughton 1983; Pouzet et al. 1999; Deacon et al.
2002; Bannerman et al. 2003; Bast and Feldon 2003).
Consistent with the hypothesis that fear and anxiety are sub-
served by the septo-hippocampal system (Gray 1982), lesions in
themurine ventral hippocampus lead to an anxiolytic phenotype
(Bannerman et al. 2004). Anxiety-related behavior did not differ
between treatment groups, which contrasted with the anxiolytic
phenotype previously reported in SynGAP1+/2 mice (Guo et al.
2009; Muhia et al. 2010). This outcome suggests that adult loss
of SynGAP1 might not alter anxiety-related behavior when its
deletion is restricted to the hippocampus. It is therefore plausible
that the anxiolytic phenotype of SynGAP1+/2 mice stems from
SynGAP1 disruption outside the hippocampus and/or from
changes in developmental mechanisms that manifest later in
adulthood. This suggests possible divergent roles of SynGAP1 dur-
ing development and adulthood in some behavioral functions.
Conclusion
In summary, weprovide the first in vivo evidence for the impact of
adult SynGAP1 deficiency on hippocampal morphology, physiol-
ogy, and hippocampus-dependent cognitive and non-cognitive
behavioral processes. Collectively, the anomalous changes indi-
cate that hippocampus-specific SynGAP1 loss is sufficient to alter
distinct functions known to depend on NMDAR and hippocam-
pal integrity. We have also shown that changes associated with
SynGAP1 deficiency cannot be wholly attributed to its malfunc-
tion during development by demonstrating similar features with
adult hippocampus SynGAP1 knockout (Komiyama et al. 2002;
Guo et al. 2009; Muhia et al. 2009, 2010). SynGAP1 therefore
continues to play a critical role in adulthood by possibly mediat-
ing similar biochemical cascades following NMDAR activation.
This represents a significant step toward a finer delineation of
SynGAP1’s role in adult synaptic function.
Materials and Methods
Subjects
The generation of the SynGAP1 homozygous floxed mice (SGflox/
flox) has been described and published elsewhere (Vazquez et al.
2004; Knuesel et al. 2005). Briefly, the transgenic SGflox/flox line
harbors two loxP sites flanking the sequence between exons 4
and 9, which encode the PH, C2, and GAP domains (Fig. 1A).
Thus, excision of the loxP-flanked SynGAP1 gene coding sequence
by Cre recombinase eliminates all SynGAP1 isoforms (Vazquez
et al. 2004). SGflox/flox mice were back-crossed and maintained in
a C57BL/6 background. They were bred at our in-house facility
(Laboratory of Behavioral Neurobiology, ETH Zurich, Schwerzen-
bach, Switzerland). At 3 wk of age, the mice were weaned, sexed,
and genotyped by PCR of isolated genomic DNA (see Knuesel
et al. 2005). They were kept under a reversed light–dark cycle
(lights on from 1900 to 0700 h) in a temperature (21˚C+1˚C)
and humidity (55%+5%) controlled room. Food (Kliba 3430)
and water were available ad libitum. The subjects were singly
caged following the surgical procedure (see below) at 8–10 wk
of age. For behavioral evaluation, a cohort comprising 34 SGflox/
flox mice received intrahippocampal microinjections of either
the control (rAAV-EGFP) viral vectors (eight SGflox/flox mice per
sex) or Cre expressing (rAAV-EGFP-Cre) vectors (nine SGflox/flox
mice per sex).Wehad previously established in a pilot study stable
transgene expression, peaking at 4wk post-microinjection. Hence,
behavioral experiments commenced 4 wk post-surgery at 12–14
wk of age and were all performed in the dark phase of the light–
dark cycle. An additional behaviorally naive cohort, age-matched
against the behaviorally tested cohort, and consisting of 32 SGflox/
floxmice (n ¼ 8 per viral vector and sex) underwent a similar surgi-
cal procedure and housing conditions. This cohort was destined
for immunohistochemical analyses and was sacrificed to coincide
with the conclusion of behavioral experiments. A third age-
matched cohort of mice was prepared for electrophysiological re-
cordings, involving unilateral intrahippocampal injections (n ¼
3–4 per viral vector). All procedures were performed under exper-
imental approval by the Cantonal Veterinary Office, Zurich (Swiss
Animal protection Act, 1978), and conform to the European
Council Directives 86/609/EEC on animal experimentation.
Plasmid construction
The Klenow-blunted SalI-NLS Cre-XbaI fragment of pCMV-NLS
Cre was inserted into the Klenow-blunted and HindIII-restricted
pEGFP-C1 (Clontech) to generate pEGFP-NLS Cre. Subsequently,
the NheI-EGFP-NLS Cre-MluI fragment of pEGFP-NLS Cre was in-
serted into the NheI–MluI-restricted AAV-2 vector plasmid psub-
2-hPDGFb-WPRE (Paterna et al. 2000) to obtain psub-2-hPDGFb-
EGFP-NLS Cre-WPRE. Oligodeoxynucleotides (Microsynth AG)
encoding the 24-amino-acid foot and mouth disease (FMDV) 2A
sequence (APVKQTLNFDLLKLAGDVESNPGP) were hybridized
and inserted into the NheI–MluI restricted psub-2-hPDGFb-
WPRE to produce psub-2-hPDGFb-2A-WPRE. The PCR-amplified
PacI-EGFP–SacI fragment of pEGFP-N1 was inserted into the
PacI–SacI-restricted psub-2-hPDGFb-2A-WPRE upstream and in-
frame of the FMDV 2A sequence to generate psub-2-hPDGFb-
EGFP-2A-WPRE. The PCR-amplified SpeI-NLS Cre-MluI fragment
of psub-2-hPDGFb-EGFP-NLS Cre-WPRE was then inserted into
the SpeI–MluI restricted psub-2-hPDGFb-EGFP-2A-WPRE down-
stream and in-frame from the FMDV 2A sequence to generate
psub-2-hPDGFb-EGFP-2A-NLS Cre-WPRE. The PCR-amplified PacI-
AAV-8 cap genes-PmeI fragment of plasmid p5E18-VD2/8 (James
Wilson, University of Pennsylvania, PA) was inserted into the
PacI–PmeI-restricted hybrid AAV/adenovirus (AV) helper plasmid
pJCP-AAV-5 (Pietropaolo et al. 2007) to generate pJCP-AAV-8.
Production, purification, and titration of recombinant
adenovirus-associated viral (rAAV) vectors
Wegenerated the recombinant adenovirus-associated viral (rAAV)
vectors by the transient calciumphosphate precipitationmethod.
Briefly, 70%–80% confluent human embryonic kidney (HEK)
293T cells were transfected with a 1.5:1 molar ratio of AAV-2 vec-
tor plasmids and hybrid AAV/AV helper plasmids. Forty-eight to
72 h post-transfection, cells were collected and lysed in AAV lysis
buffer (150 mMNaCl, 50 mM Tris-HCl at pH 8.5) by three freeze–
thaw cycles. Crude cell lysate was incubated for 30 min at 37˚C
with Benzonase (50 U/mL), cleared by low-speed centrifuga-
tion, and purified by iodixanol gradient ultracentrifugation
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(Zolotukhin et al. 1999). The rAAV vector–containing fractions
were collected, and the iodixanol was removed by 100-kDa ultra-
filtration (Vivaspin 20; Sartorius) using phosphate-buffered saline
(PBS) containing 1 mM Mgcl2 and 2.5 mM KCl (PBS-MK buffer).
Physical titers (vector genomes per milliliter, vg/mL) were mea-
sured by quantitative real-time PCR using primers specific for
the simian virus (SV) 40 polyadenylation signal [poly(A)]. Physical
titers were estimated at 1 × 1013 vg/mL for the rAAV vector prep-
arations used in the present study.
Stereotaxic intra-hippocampal injections of rAAV vectors
General anesthesia was achieved by intra-peritoneal (i.p.) injec-
tion of the following mixture diluted in 0.9% Saline: Dormicum
(Midazolam, 0.15 mg/kg BW, Roche Pharma); Domitor (Medeto-
midin, 15 mg/kg BW, Orion), and Fentanyl (1.5 mg/kg BW, Jans-
sen-Cilag Pharma). The animal’s head was positioned and fixed
in a Kopf stereotaxic frame (David Kopf Instruments). Infusions
of the rAAV vectors were made through a 34-gauge stainless steel
cannula (Cooper’s Needle) fitted into a 5-mL 5R-GPS SGE syringe
(SGE Analytical Science Pty Ltd). Two micro-injections of 1 mL
and 0.5 mL (of a 1:1 [v/v] mixture of the rAAV-5/2 and rAAV-8/2
vectors) were made per hemisphere, targeting the dorsal and
ventral hippocampus, respectively. The coordinates targeting
the dorsal and ventral hippocampus were based on the mouse
brain stereotaxic atlas by Paxinos and Franklin (2001). The coordi-
nates (anterior–posterior [AP] from Bregma, medio–lateral [ML]
measured from midline of central sinus, and dorso–ventral [DV]
from the dura surface] were as follows: 22.0 mm AP, +1.7 mm
ML, and 22.0 mm DV for the dorsal hippocampus; 23.3 mm AP,
+3.0 mm ML, and 23.2 mm DV for the ventral hippocampus. A
small holewas drilled through the skull before the cannulawas in-
serted into the area of interest and left for 5 min before vector
delivery. Stepwise delivery (0.25 mL) of the viral vector was per-
formed by retracting the cannula to 21.4 mm (DV: dorsal) and
22.6 mm (DV: ventral) in order to achieve optimal vector spread
in thehippocampus. The vectorwas deliveredmanually at 0.2 mL/
min. At the end of infusion, the cannula was left in place for
2 min, retracted 1 mm, and left in place for an additional 3 min
before being slowly withdrawn from the brain. Fifteen minutes
post-surgery, the animals received a subcutaneous injection of an-
tagonist in order to reverse the effects of the general anesthesia.
The following mixture was diluted in 0.9% saline: Antisedan (Ati-
pamezol, 0.75 mg/kg BW, Pfizer, Orion pharma), Anexate (Fluma-
nezil, 0.2 mg/kg BW, Roche), and Naloxon (Narcan, 0.4 mg/kg
BW, Swiss GmbH).
Laser microdissection
Immunofluorescently labeled coronal brain sections (10 mm
thick) were mounted on gelatinized glass slides (Thermo Fisher
Scientific) and kept in a moist chamber for subsequent laser mi-
crodissection. The slides were placed onto the stage of the PALM
MicroBeam system (Zeiss). Epifluorescence microscopy was used
to visualize EGFP-positive neurons using a 40× objective (NA
1.4). Individual cells were then outlined using the PALM
RoboSoftware 3.2. graphic tools (as shown in Fig. 2B). A nitrogen
(337 nm) laser, focused through the 40× objective lens, cut
around (laser microdissection) and catapulted (pressure catapult-
ing) (Fig. 2C) selected cells into the lid of a 0.5-mL capturing
Microfuge tube (PALM, Zeiss). Following this, 25 mL of distilled
water was added to the lid, and the catapulted cells were trans-
ferred from the lid to the bottom of the Microfuge tube by brief
centrifugation. A total of eight to 10 EGFP-positive cells from
each treatment group (rAAV-EGFP and rAAV-EGFP-Cre) were col-
lected for DNA isolation.
PCR confirmation of gene deletion
The isolated cells were subjected to genomic DNA extraction
(QIAamp DNA Micro, QIAGEN) and subsequent nested PCR
(Figs. 1A, 2D) (first-stage primer pair: MGEX9-I [forward]:
5′-CGGATGCTATGTGCAGTGCTGGA-3′ and MGINII [reverse]:
5′-GAGAGAGATGGAGGGTCACTTGAG-3′; second-stage primer
pair: 5 SynGAP1-1 [forward]: 5′-ATGTGCTGTGAGTTGGCC-3′
and nested 3 SynGAP1 n [reverse]: 5′-TATCTCACGGCCCTGG-3′).
The presence of genomic DNA in all samples after LDM and
LPC was confirmed by nested PCR as described above except
that the first-stage forward primer MGEX9-I was replaced with
a primer that binds within the SynGAP1 gene irrespective of its re-
combination status (loxDS: 5′-GAAGAGGAGTTTACGTCCAGCC
AAGCT-3′). If no Cre-mediated recombination occurred, a weak
diagnostic 1800-bp PCR product was detectable after the first-
stage PCR. Amplification of this weak signal during the second-
stage PCR resulted in a strong 400-bp PCR product (Fig. 2D).
Electrophysiology
Mice were anesthetized with isofluorane and decapitated.
Transversal hippocampal slices (250 mm) were cut using a vibrat-
ing microtome (Leica). Slicing was done in an ice-cold solution
containing 87 mM NaCl, 75 mM sucrose, 25 mM glucose,
25 mM NaHCO3, 7 mM MgCl2, 2.5 mM KCl, 1.25 mM NaH2PO4,
and 0.5 mM CaCl2. After cutting, slices were incubated for
30 min at 35˚C in artificial cerebrospinal fluid (ACSF), also used
as extracellular solution for the experiments. The solution con-
tained 125 mM NaCl, 26 mM NaHCO3, 1.25 mM NaH2PO4
∗
H2O, 2.5 mM KCl, 1.0 mM MgSO4, 2.5 mM CaCl; 310 mOsmol
and pH 7.4 when bubbled with a gas mixture containing 95%
O2, 5% CO2. Slices were carefully separated in injected and non-
injected hemispheres. Whole-cell voltage-clamp (260 mV) re-
cordings of spontaneous excitatory events (sEPSCs) were per-
formed at 33˚C, using an internal solution containing 125 mM
KMeSO4, 20 mM HEPES, 14 mM Tris-phosphocreatine, 5 mM
Na2-ATP, 5 mM KCl, and 0.3 mM Tris-GTP. Patch electrodes were
pulled fromborosilicate pipettes (5–7MV tip resistance) on a hor-
izontal puller (Zeitz). Currents were amplified using aMulticlamp
700A amplifier (Axon Instruments), filtered at 10 kHz, and digi-
tized at 20 kHz (IGORPro). After recording, sliceswere immediate-
ly fixed in 4% paraformaldehyde, 15% saturated picric acid, and
0.1 M phosphate buffer (pH 7.4) overnight at 4˚C, transferred to
20% sucrose and stored at 220˚C in cryoprotectant solution until
post hoc immunohistochemical analyses (see below).
Data analysis
Analysis and filtering (at 2 kHz) of sEPSCs was performed by using
the Mini Analysis Program (Synaptosoft, Version 6.0.3). Somatic
recordings with an access resistance. 27 MV and a leak
current.200 pA were excluded. Out of 10 min of recording
time, the most stable 2-min period was taken for the analysis.
sEPSCs were detected by the following search parameters: (gain,
15; blocks, 8;) threshold, 10–15 pA; period to search for a local
maximum, 20 msec; time before a peak for baseline, 5 msec; peri-
od to search a decay time, 5 msec; fraction of peak to find a decay
time, 0.5; period to average at baseline, 2 msec; area threshold, 9–
13; number of points to average for peak, 3; direction of peak, neg-
ative. The significance of event intervals and amplitudes was cal-
culated by a statistical comparison between ipsilateral and
contralateral sides using the Kolmogorv-Smirnov-Test. Figures
were created by using IGOR Pro software.
Immunohistochemistry
Themicewere anesthetizedwith an overdose of sodiumpentobar-
bital (40 mg/kg BW [body weight]) and perfused transcardially
with 4% phosphate-buffered paraformaldehyde solution contain-
ing 15%picric acid. The brainswere removed andpost-fixed in the
same fixative for 3 h. The brains were rinsed in phosphate-
buffered saline (PBS, pH 7.4), cryoprotected in 30% sucrose for
24 h, and stored at 280˚C. Sections (40 mm thick) were cut coro-
nally from frozen blockswith a slidingmicrotome, and 12 random
sampled serial sections fromBregma20.8 mm to23.20 mmwere
collected, rinsed in PBS, and stored at 220˚C in cryoprotectant
solution until further processing.
Before immunohistochemical staining, all brain sections
were treated with pepsin (DAKO). Frozen aliquots containing
3 mg/mL pepsin solution in 0.2 N HCl were thawed immediately
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before use and added to 0.2 N HCl to a final pepsin concentration
of 0.15 mg/mL. Free-floating brain sections were incubated in
pepsin solution for 10 min at 37˚C and washed briefly in PBS.
For immunostaining, free-floating sections were rinsed three
times for 10 min in Tris buffer (TBS, 50 mM Tris, 150 mMNaCl at
pH 7.4) containing 0.2% Triton X-100 (TBST). The sections were
then transferred in primary antibody diluted in TBST containing
2% normal goat serum (NGS) and incubated overnight in a moist
chamber at 4˚C. The primary antibodies used in the study are de-
picted in Table 1.
Fluorescence staining
On the following day, the sectionswere rinsed three times (10 min
each) in TBST, before they were incubated for 30 min in goat–
anti-rabbit or mouse Cy3 or Cy5 (1:500 each; Jackson Immuno-
Research Laboratories) diluted in TBST containing 2% NGS. Fol-
lowing this, they were rinsed three times for 10 min each with
PBS. They were mounted on gelatin-coated slides and allowed to
air-dry for 30 min. Finally, they were coverslippedwithDako fluo-
rescent mounting medium (Dako).
DAB staining
After three washes (each 10 min) in TBST, the sections were incu-
bated for 30 min at room temperature in biotinylated secondary
antibody (1:300; Jackson ImmunoResearch) diluted in TBST con-
taining 2% NGS. Sections were washed again three times (10 min
each) in TBST and incubated in the Vectastain Kit (Vector
Laboratories) diluted in TBST for 30 min. After a further three
washes in TBST, the sections were stained with 3,3-diaminobenzi-
dine (DAB) and 0.05% H2O2 for 8–20 min and rinsed again three
times in PBS before mounting on gelatin-coated slides and dried
overnight. Finally, they were dehydrated through an alcohol se-
ries, cleared with xylene, and coverslipped with Eukid (Kindler
GmbH).
Microscopy
Qualitative evaluation of immunofluorescence stainings was
done with confocal microscopy (LSM-710, Zeiss) using either
10× (NA 0.45) for mosaic images, 40× (NA1.3), or 63× plan apo-
chromat objectives (NA 1.4) for high-magnification imaging.
Double-fluorescence stainings were visualized using sequential
acquisition of each channel. The pinhole aperture was set to 1.0
Airy unit for each channel. Stacks of consecutive optical sections
(12; 512 × 512 pixels, spaced 0.5 mm in z) were acquired at a mag-
nification of 0.13 mm/pixel. For visual display, Z-sections of all
channels were projected in the z-dimension (maximal intensity),
and merged using the image analysis software Imaris (Bitplane).
Cropping of images and adjustments of brightness and contrast
were identical for each labeling and done using Adobe
Photoshop (CS3, Version 10.0.1, Adobe Systems).
Quantification of GluA1- and NR1-positive clusters
Quantitative analyses of the immunohistochemical stainings
using anti-GluA1 and -NR1 antibodies were performed on a ran-
domly selected hemisphere and performed blind to the viral ex-
pression construct (rAAV-EGFP controls, or rAAV-EGFP-Cre).
Single stack digital images from four brain sections per animal
were acquired from CA1 stratum radiatum, CA3 stratum radiatum
and lucidum, and the DG molecular layer. The size, number, and
sum pixel brightness of the GluA1- or NR1-immunoreactive clus-
ters were quantified by segmentation of the binary images using a
fixed threshold algorithmof ImageJ software (NIH; http://rsbweb.
nih.gov/ij/).
Optical densitometry
Quantification of Iba-1 and SynGAP1 immunoreactivity was
achieved bymeans of optical densitometry using ImageJ software.
Digital images (n ¼ 4 brain sections per sex and treatment) were
acquired using an Axiocam MRc5 (Zeiss) digital camera mounted
on a Zeiss Lumar V12 Stereomicroscope with a 0.8× NeoLumar S
objective. Exposure time was held constant during acquisition of
all images. Pixel brightnesswasmeasured on one randomly select-
ed hemisphere in the outlined subregions of the hippocampus
(DG molecular layer, CA1 stratum radiatum, CA3 stratum radia-
tum and lucidum, CA4 stratum radiatum), as well as in the corpus
callosum, which served as background area. The background-
corrected pixel brightness was averaged per brain region and
animal.
Counting of Doublecortin (DCX)–positive neurons
DCX-positive cells in the dentate gyrus subgranular zone were
counted exhaustively on both hemispheres of four to five sections
per animal using live microscopy with a 40× objective (NA 1.3).
The cells counted were averaged per hemisphere and animal.
Behavioral experiments
Elevated plus maze test
The elevated plusmaze test exploits the approach–avoidance con-
flict, which involves the natural tendency of rodents to explore a
novel environment and the aversive properties of an open area
(Handley and Mithani 1984). The apparatus was made of opaque
Plexiglas with a removable plastic gray floor as described previous-
ly (Hagenbuch et al. 2006). It consisted of four interconnected
elevated stem arms (30 cm long × 5 cm wide) radiating from a
central square measuring 5 × 5 cm and raised 70 cm above the
floor. The maze was positioned in the middle of the experimental
room with diffuse dim lighting (25 lux in the center of the maze).
One pair of opposing arms was enclosed with a perimeter wall
made of opaque Plexiglas (14 cmhigh); the other pair of opposing
arms was exposed. Here, the test session lasted 5 min, during
which the animals were allowed to explore the maze freely before
being removed and returned to the home cage. The following
measures were recorded using the Ethovision (Noldus Tech-
nology) tracking system: (1) Percentage frequency of entries
made to the open arms ¼ (entries into open arms/entries into
all arms × 100%), (2) Percentage time spent in the open arms ¼
(time in open arms/time in all arms × 100%), and (3) distance
traveled in the maze during the 5-min session.
Table 1. Summary of antibodies used for immunohistochemical
staining (in alphabetical order)





















1:1000 Millipore Guinea pig
polyclonal,
AB2253
GFAP 1:5000 DAKO Schweiz AG Rabbit polyclonal,
Z334
GFP 1:5000 Novus Biologicals Ltd Mouse
monoclonal,
NB600-597




NMDA NR1 1:1000 Millipore Rabbit polyclonal,
AB1516
SynGAP 1:3000 ABR Rabbit polyclonal,
PA1-046
VGlut1 1:5000 Millipore Guinea pig
polyclonal,
AB5905
Hippocampal deletion of SynGAP1
www.learnmem.org 278 Learning & Memory
 Cold Spring Harbor Laboratory Press on April 9, 2015 - Published by learnmem.cshlp.orgDownloaded from 
Spontaneous open field activity
The open field and the procedure have been previously described
(Hauser et al. 2005). Each subject was gently placed in the center
of the open field and allowed to explore freely for 60 min.
Locomotor activity was indexed by the distance moved (in me-
ters) across successive 10-min bins.
Spatial novelty preference test
Spatial recognition memory was evaluated by spontaneous alter-
nation task in the Y-maze in accordance with Sanderson et al.
(2007) and Bannerman et al. (2008). This task assessed short-term
spatial memory and uses the natural tendency for rodents to ex-
plore novel over familiar spatial environments. The procedure
was performed in a Y-maze elevated 90 cm above the floor and po-
sitioned in the middle of a dimly lit (30 lux in the center of the
maze) experiment room. A digital camera mounted above the
maze captured images at a rate of 5 Hz, which were then transmit-
ted to a PC running the Ethovision tracking system (Noldus
Technology).
Apparatus
The apparatus was made of transparent Plexiglas and consisted of
three identical arms (50 cm × 9 cm; length × width) surrounded
by 10-cm-high transparent Plexiglas walls. The three arms radiat-
ed from a central triangle (8 cm on each side) and spaced 120˚
from each other. Access to each arm from the central area could
be blocked by a removable opaque barrier wall. The floor of the
maze was covered with sawdust bedding, which was changed be-
tween testing phases as well as between trials. Three identical
Y-mazes, each housed in a distinct testing room, were used here
for each retention interval tested (see later). In addition, testing
was performed in three different experimental rooms, each con-
taining a unique set of extra-maze cues. The allocation of arms
(start, familiar and novel arm) to a specific spatial location was
counterbalanced across subjects.
Sample phase
The subjects were assigned two arms (start arm and familiar arm)
to which they were exposed during this phase. Access to the re-
maining arm (novel arm) was blocked by a barrier wall door.
The subject was introduced at the end of the start arm, facing
the central triangle and allowed to freely explore both the start
and familiar arms for 5 min. Testing time was initiated once the
subject had made an entry into the central triangular area, as de-
tected by the Ethovision tracking system. The subject was then re-
moved and kept in a holding cage for 2 min (0 min delay) or
returned to the home cage for the 15-min or 1-h retention inter-
vals before the test phase. The barrier door was removed and the
sawdust flooring changed to avoid olfactory cues.
Test phase
The remaining third arm constituted the novel arm during this
phase. Following the retention interval, the test subject was intro-
duced to the maze, with the barrier wall removed, and allowed to
freely explore the maze for 3 min. The subject was then removed
from the maze and returned to its home cage. The sawdust floor-
ing was changed in preparation for the next trial. On each trial,
the time spent in each of the three arms was recorded for both
the sample and test phases. For the test phase, the percentage
time spent in the novel arm—[(time in the novel arm)/(time in
the novel + time in familiar arm)] × 100%—was calculated as an
index for spatial novelty preference.
Morris water maze test: reference memory and reversal learning
Spatial reference memory and reversal learning were evaluated in
theMorris water maze task. The water maze consisted of a circular
tank made of white fiberglass. It measured 1 m in diameter and
was filled daily with fresh tap water maintained at 22˚C+2˚C.
Four equally spaced cardinal points (N, S, E, andW)were designat-
ed on the circumference of the pool and served as the starting
points, from which the animals were released facing the wall of
the water maze. A solid cylinder made of transparent Plexiglas
(diameter 7 cm, height 18.5 cm) served as the escape platform
and was submerged beneath the water surface to a depth of
1.5 cm, and therefore invisible to the animals. The maze was po-
sitioned in the middle of a dimly lit (80 lux on the water surface)
experimental room that was equipped with several extra-maze
cues. Automated swim path monitoring was provided by the
Ethovision tracking system (Noldus Technology).
Visible platform training
On day 1, the mice were tested on four consecutive trials (ITI ¼
1 min) in the cued version of the task to find a submerged plat-
form that was indicated by a salient local cue visible above thewa-
ter level. This was performed to assess the general motivation to
escape from water and rule out any visual or motor deficits. The
escape platform was positioned in the center of the water maze,
and the starting positions were varied randomly among the four
possible starting points (S, E, N, andW). A trial endedwhen an an-
imal escaped onto the platform or when 60 sec had elapsed, after
which the animal would be guided to the platform by the exper-
imenter. The animals were allowed to spend 30 sec on the plat-
form and then placed into a waiting cage for a further 30 sec
before the next trial began.
Hidden platform training
On days 2–8, the animals were trained to locate the escape plat-
form (7 cm in diameter) submerged 1 cm below the water surface
in a constant location (middle of SE quadrant). The starting
positions were varied in a pseudorandom sequence across two
trials, with N, E, S, and W each being used once. The variables
used to determine performance in the task included escape laten-
cy (in seconds) and distance swum to reach the platform (in
centimeters).
Probe test 1
On day 9, a 60-sec probe test was conducted with the platform re-
moved from the water maze and with the starting position (NW)
for all subjects. Performance was evaluated by percent distance
and time spent in the target quadrant in comparisonwith the oth-
er quadrants.
Reversal learning
Reversal learning was performed from days 10 to 15. The hidden
platform was shifted to the middle of the opposite quadrant
(NW), and training was performed as described in the reference
memory subsection.
Probe test 2
Following reversal training, a 60-sec probe test was performed on
day 16 as described before. The starting position (SE) was constant
for all subjects.
Statistical analysis
In the behavioral experiments, data were subjected to parametric
analysis of variance (ANOVA), with between-subject factors:
Treatment (rAAV-EGFP vs. rAAV-EGFP-Cre) and Sex (male vs. fe-
male). The following repeated measures (within-subjects) factors
as appropriated by the design of the experiment included Bins,
Delays, or Days. These were supplemented by restricted ANOVAs
whenever appropriate to aid the interpretation of complex inter-
action effects stemming from the overall multi-factorial ANOVA.
In addition, Fisher’s LSD pairwise comparisons were implemented
to examine significant main effects as well as interaction terms.
A two-tailed Type I error rate of P, 0.05 was adopted as the
yardstick for statistical significance. For immunohistochemical
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analysis, the Kolmogorov-Smirnov non-parametric analysis was
performed to determine cluster size distribution of GluR1- and
NR1-immunoreactive puncta. An independent Student’s t-test
was used for statistical comparison between treatment groups
for the anti-Iba1 and SynGAP1 densitometrical analysis. All anal-
yses were performed using SPSS for Windows (version 19, SPSS
Inc.) implemented on a PC running the Windows XP (SP2) oper-
ating system.
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